SEARCH

SEARCH BY CITATION

References

  • 1
    Haynes BF, Hemler ME, Mann DL et al . Characterization of a monoclonal antibody (4F2) that binds to human monocytes and to a subset of activated lymphocytes. J Immunol 1981; 126: 140914.
  • 2
    Broer S, Broer A, Hamprecht B. The 4F2hc surface antigen is necessary for expression of system 1-like neutral amino acid-transport activity in C6-BU-1 rat glioma cells: evidence from expression studies in Xenopus laevis oocytes. Biochem J 1995; 312 (Pt 3): 86370.
  • 3
    Kanai Y, Segawa H, Miyamoto K, Uchino H, Takeda E, Endou H. Expression cloning and characterization of a transporter for large neutral amino acids activated by the heavy chain of 4F2 antigen (CD98). J Biol Chem 1998; 273: 23 62932.
  • 4
    Hashimoto Y, Masuko T, Yagita H, Endo N, Kanazawa J, Tazawa J. A proliferation-associated rat cell surface antigen recognized by a murine monoclonal antibody. Gann 1983; 74: 81921.
  • 5
    Masuko T, Abe J, Yagita H, Hashimoto Y. Human bladder cancer cell-surface antigens recognized by murine monoclonal antibodies raised against T24 bladder cancer cells. Jpn J Cancer Res 1985; 76: 38694.
  • 6
    Yagita H, Masuko T, Hashimoto Y. Inhibition of tumor cell growth in vitro by murine monoclonal antibodies that recognize a proliferation-associated cell surface antigen system in rats and humans. Cancer Res 1986; 46: 147884.
  • 7
    Yagita H, Masuko T, Takahashi N, Hashimoto Y. Monoclonal antibodies that inhibit activation and proliferation of lymphocytes. I. Expression of the antigen on monocytes and activated lymphocytes. J Immunol 1986; 136: 205561.
  • 8
    Hara K, Kudoh H, Enomoto T, Hashimoto Y, Masuko T. Malignant transformation of NIH3T3 cells by overexpression of early lymphocyte activation antigen CD98. Biochem Biophys Res Commun 1999; 262: 7205.
  • 9
    Goldenberg MM. Trastuzumab, a recombinant DNA-derived humanized monoclonal antibody, a novel agent for the treatment of metastatic breast cancer. Clin Ther 1999; 21: 30918.
  • 10
    Anderson DR, Grillo-Lopez A, Varns C, Chambers KS, Hanna N. Targeted anti-cancer therapy using rituximab, a chimaeric anti-CD20 antibody (IDEC-C2B8) in the treatment of non-Hodgkin's B-cell lymphoma. Biochem Soc Trans 1997; 25: 7058.
  • 11
    Maini RN, Breedveld FC, Kalden JR et al . Therapeutic efficacy of multiple intravenous infusions of anti-tumor necrosis factor alpha monoclonal antibody combined with low-dose weekly methotrexate in rheumatoid arthritis. Arthritis Rheum 1998; 41: 155263.
  • 12
    Riemer AB, Kurz H, Klinger M, Scheiner O, Zielinski CC, Jensen-Jarolim E. Vaccination with cetuximab mimotopes and biological properties of induced anti-epidermal growth factor receptor antibodies. J Natl Cancer Inst 2005; 97: 166370.
  • 13
    Li M, Yan Z, Han W, Zhang Y. Mimotope vaccination for epitope-specific induction of anti-CD20 antibodies. Cell Immunol 2006; 239: 13643.
  • 14
    Riemer AB, Klinger M, Wagner S et al . Generation of peptide mimics of the epitope recognized by trastuzumab on the oncogenic protein Her-2/neu. J Immunol 2004; 173: 394401.
  • 15
    Riemer AB, Forster-Waldl E, Bramswig KH et al . Induction of IgG antibodies against the GD2 carbohydrate tumor antigen by vaccination with peptide mimotopes. Eur J Immunol 2006; 36: 126774.
  • 16
    Bolesta E, Kowalczyk A, Wierzbicki A et al . DNA vaccine expressing the mimotope of GD2 ganglioside induces protective GD2 cross-reactive antibody responses. Cancer Res 2005; 65: 341018.
  • 17
    Horwacik I, Czaplicki D, Talarek K et al . Selection of novel peptide mimics of the GD2 ganglioside from a constrained phage-displayed peptide library. Int J Mol Med 2007; 19: 82939.
  • 18
    Itoh K, Inoue K, Hayashi H, Suzuki T, Masuko T. Identification of cell proliferation-associated epitope on CD98 oncoprotein using phage display random peptide library. Cancer Sci 2007; 98: 1696700.
  • 19
    Itoh K, Suzuki K, Ishiwata S, Tezuka T, Mizugaki M, Suzuki T. Application of a recombinant Fab fragment from a phage display library for sensitive detection of a target antigen by an inhibition ELISA system. J Immunol Meth 1999; 223: 10714.
  • 20
    Itoh K, Inoue K, Hirooka K et al . Phage display cloning and characterization of monoclonal antibody genes and recombinant Fab fragment against the CD98 oncoprotein. Jpn J Cancer Res 2001; 92: 131321.
  • 21
    Kabat EA, Wu TT, Perry HM, Gottesman KS, Foeller C. Sequences of Proteins of Immunological Interest. Washington: Department of Health and Human Services, Public Services, NIH, 1991.
  • 22
    Barbas CF, Kang AS, Lerner RA, Benkovic SJ. Assembly of combinatorial antibody libraries on phage surfaces: the gene III site. Proc Natl Acad Sci USA 1991; 88: 797882.
  • 23
    Scherer WF, Syverton JT, Gey GO. Studies on the propagation in vitro of poliomyelitis viruses. IV. Viral multiplication in a stable strain of human malignant epithelial cells (strain HeLa) derived from an epidermoid carcinoma of the cervix. J Exp Med 1953; 97: 695710.
  • 24
    Eggena M, Targan SR, Iwanczyk L, Vidrich A, Gordon LK, Braun J. Phage display cloning and characterization of an immunogenetic marker (perinuclear anti-neutrophil cytoplasmic antibody) in ulcerative colitis. J Immunol 1996; 156: 400511.
  • 25
    Li M, Han W, Zhang Q, Xue X, Wang Z, Zhang Y. Development of a mimotope-based vaccine against CD20 antigen. Protein Pept Lett 2007; 14: 61014.
  • 26
    Oldstone MB. Molecular mimicry, microbial infection, and autoimmune disease: evolution of the concept. Curr Top Microbiol Immunol 2005; 296: 117.
  • 27
    Jerne NK. The somatic generation of immune recognition. Eur J Immunol 1971; 1: 19.
  • 28
    Fischer EA, Curd JG, Chaiken IM. Preparation of biologically active conjugates of bovine neurophysins and other polypeptides with multi-(poly-d,1-alanyl)–poly-l-lysine and their use to elicit antibodies. Immunochemistry 1977; 14: 595602.
  • 29
    Harper S, Speicher DW. In: Coligan JE, Dunn BM, Ploegh HL, Spiecher DW, Wingfield PT, eds. Expression and purification of GST fusion proteins. Curr Protoc Protein Sci. Hoboken: John Wiley & Sans, 2001: Chapter 6: Unit 6; 126.
  • 30
    Torchilin VP, Levchenko TS. TAT-liposomes: a novel intracellular drug carrier. Curr Protein Pept Sci 2003; 4: 13340.